Fu et al. (2007) examined PLCD1, another enzyme from the PLC family, noting increased methylation in its promoter region’s CpG islands, causing reduced gene expression in various malignant tumors, such as esophageal cancer [63]. The gene discussed is HSPG2; the disease is cancer.